文献速递骨显像与常规 SPECT肿瘤 PET/CT

定量CT在肿瘤患者18F-FDG PET/CT中检出未诊断的低骨密度

Quantitative CT Detects Undiagnosed Low Bone Mineral Density in Oncologic Patients Imaged With 18F-FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2021-01-01

本研究回顾性分析100例接受18F-FDG PET/CT的肿瘤患者,用定量CT评估腰椎和股骨颈骨密度。50岁及以上患者中骨质疏松和骨量减少分别占16%和46%,骨髓SUVmax与腰椎骨密度相关,L1 CT值可准确识别骨折风险增高者。

要点

  • 肿瘤患者中低骨密度常见,50岁及以上者骨质疏松占16%、骨量减少占46%。
  • 骨髓SUVmax与腰椎骨密度正相关(ρ=0.36,P<0.001)。
  • L1 CT值检测骨质疏松相关骨折风险增高的AUC为0.95,最佳阈值125.8 HU。

核心结论

  • 接受18F-FDG PET/CT的肿瘤患者中低骨密度常见。
  • 骨髓18F-FDG摄取降低与骨密度降低相关,支持骨质疏松与骨髓脂肪的关联。
  • L1 CT值可简单准确地从PET/CT数据中识别骨质疏松相关骨折风险增高的患者。

研究设计与样本

  • 单中心回顾性分析纳入2015年10月至2016年5月接受18F-FDG PET/CT的100例肿瘤患者。
  • 采用定量CT评估腰椎骨密度(BMDQCT)和股骨颈骨密度(BMDCTXA)。
  • 用骨髓SUVmax评估骨髓代谢活性,用股骨颈BMDCTXA和FRAX算法计算骨质疏松相关骨折风险,并与L1松质骨CT值(L1HU)比较。

主要发现

  • 50岁及以上患者中骨质疏松占16%,骨量减少占46%。
  • 骨髓SUVmax与腰椎骨密度相关(ρ=0.36,P<0.001)。
  • 年龄增加和骨髓SUVmax降低与腰椎低BMDQCT相关(均P<0.001)。
  • 年龄增加、女性、骨髓SUVmax降低与股骨颈低BMDCTXA相关(P<0.001、P<0.001、P=0.01)。
  • L1HU检测骨质疏松相关骨折风险增高的AUC为0.95(95%CI 0.90-0.99),最佳阈值125.8 HU(95%CI 115.7-144.9),敏感度100%(95%CI 0.92-1.00),特异度0.90(95%CI 0.76-0.97),准确率0.91(95%CI 0.79-0.97)。

关键数值与推荐

  • 骨质疏松和骨量减少的患病率基于50岁及以上患者,分别为16%和46%。
  • L1HU最佳阈值125.8 HU用于检测骨质疏松相关骨折风险增高,敏感度100%、特异度0.90、准确率0.91。

临床怎么用

  • 对肿瘤患者进行18F-FDG PET/CT时,可关注骨髓SUVmax和L1 CT值以提示低骨密度和骨折风险。
  • L1HU可作为简单准确的指标,用于识别需要进一步骨质疏松评估或干预的患者。

局限性

  • 单中心回顾性分析,样本量100例。
  • 仅纳入接受18F-FDG PET/CT的肿瘤患者,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We assessed the prevalence of low bone mineral density (BMD) in oncologic patients undergoing F-FDG PET/CT. PATIENTS AND METHODS: This is a retrospective analysis of 100 patients who underwent F-FDG PET/CT at a single center from October 2015 till May 2016. Quantitative CT (QCT) was used to assess BMD at the lumbar spine (BMDQCT) and femoral necks (BMDCTXA). SUVmax was used to evaluate metabolic activity of the bone marrow. Risk of osteoporosis-related fractures was calculated with femoral neck BMDCTXA and the FRAX algorithm, which was compared against measurements of CT attenuation of the trabecular bone at L1 (L1HU). RESULTS: Osteoporosis and osteopenia were respectively present in 16% and 46% of patients 50 years and older. Bone marrow SUVmax was correlated with BMD at the lumbar spine (ρ = 0.36, P < 0.001). Increased age and low marrow SUVmax were associated with low BMDQCT at the lumbar spine (both P < 0.001), whereas increased age, female sex, and low marrow SUVmax were associated with low BMDCTXA at the femoral necks (P < 0.001, P < 0.001, P = 0.01, respectively). L1HU had an area under the curve of 0.95 (95% confidence interval [CI], 0.90-0.99) for detecting increased risk for osteoporosis-related fracture, with best threshold of 125.8 HU (95% CI, 115.7-144.9) yielding sensitivity of 100% (95% CI, 0.92-1.00), specificity of 0.90 (95% CI, 0.76-0.97), and accuracy of 0.91 (95% CI, 0.79-0.97). CONCLUSIONS: Low BMD is frequent in oncologic patients undergoing F-FDG PET/CT. Decreased F-FDG avidity of the bone marrow correlates with decreased BMD, validating the link between osteoporosis and bone marrow fat. L1HU could be a simple and accurate approach for detecting patients at risk for osteoporosis-related fractures using PET/CTdata.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kay FU, Ho V, Dosunmu EB, et al. Quantitative CT Detects Undiagnosed Low Bone Mineral Density in Oncologic Patients Imaged With 18F-FDG PET/CT. Clin Nucl Med. 2021. PMID: 33234926. doi:10.1097/RLU.0000000000003416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。